UnitedHealth Has a Bank. Now Washington Wants More Insurers to Act Like One.

By Wendell Potter – Most Americans are familiar with UnitedHealth, the largest private health insurer in America – if not because the corporate giant provides their medical coverage, then because of the massive publicity when the CEO of its key subsidiary was assassinated on a Manhattan street in December 2024. Read Full Article...

HVBA Article Summary

1. ACA Rules Encourage Insurer-Backed Medical Loans: New federal guidelines for the Affordable Care Act marketplaces suggest that insurers could finance patients’ high deductibles by offering loans. The proposal applies particularly to catastrophic and high-deductible plans, positioning borrowing as a way to manage large upfront costs. Critics argue this approach shifts the burden from reducing health care prices to expanding consumer debt. The policy reflects a broader emphasis on lowering premiums and federal spending rather than directly addressing out-of-pocket expenses.

2. UnitedHealth’s Financial Arm Highlights Potential Conflicts: UnitedHealth already operates Optum Financial, which provides health savings accounts and has extended loans to medical practices following a cyberattack. A 2025 KFF report found the company had a 33% denial rate for ACA Marketplace claims, compared with a 19% national average, and the insurer reported more than $12 billion in profits in 2025. Observers warn that combining high denial rates with loan offerings could create incentives to shift more costs onto patients. The structure raises concerns about insurers potentially benefiting both from coverage decisions and from financing the resulting bills.

3. Rising Costs and Coverage Losses Intensify Affordability Concerns: With enhanced ACA subsidies allowed to expire, some consumers have seen their 2026 monthly premiums more than double, pushing many toward lower-tier Bronze plans with steep deductibles. KFF has estimated that up to 5.5 million people could drop ACA coverage by the end of 2026, and projections suggest an additional two million may leave due to ongoing cost pressures. New rules would permit deductibles as high as $15,600 for individuals and $31,200 for families in certain plans, while catastrophic plan enrollment remains relatively low at about 67,000 people. Analysts question whether loan options will make such plans more attractive or simply increase household financial strain.

What new Medicare GLP-1 coverage means for employers

By Lee Hafner – Medicare launched an 18-month pilot program Wednesday called Medicare GLP-1 Bridge, giving eligible participants access to certain GLP-1 medications for $50 per month. While this program is separate from employer-sponsored health plans, benefits that contribute to the long-term success of these prescription drugs may soon be in higher demand. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Medicare pilot expands GLP-1 access for older workers: The 18-month Medicare GLP-1 Bridge program offers eligible Part D enrollees access to certain weight-loss medications at a reduced monthly cost. Eligibility includes individuals with a BMI of 35 or more, or those with slightly lower BMIs who also have a related condition such as prediabetes. Because many adults 65 and older remain in the workforce, employers may see increased GLP-1 usage among employees and need to consider the downstream effects. The pilot is temporary, signaling potential policy shifts but not yet a permanent change in Medicare coverage.

2. Weight regain highlights need for sustained support: An analysis of 37 studies covering more than 9,000 participants found that patients lost an average of 33 pounds on leading GLP-1 medications but regained more than 60% of that weight within a year of stopping treatment. Researchers also observed declines in improvements to blood pressure and cholesterol after discontinuation. These findings suggest that medication alone may not deliver lasting health outcomes. Employers may need to integrate structured lifestyle and behavioral programs to help employees maintain results over time.

3. Financial stakes are high for employers: The Milken Institute estimates that direct healthcare costs tied to overweight and obesity-related comorbidities total $480 billion, with lost productivity exceeding $1 trillion. Experts interviewed in the article argue that pairing GLP-1 prescriptions with coaching and lifestyle programs can improve persistence and protect muscle mass. Some employers already require participation in such programs alongside medication coverage to enhance return on investment. By aligning drug access with comprehensive support, organizations may improve long-term health outcomes while managing overall benefit costs.

Employer health premiums will rise almost 5% in 2027, forecasters predict

By Allison Bell – Increases in private employers' health care spending might start to slow, a little, in 2027. Federal government forecasters are predicting the U.S. private employers' spending on their share of health insurance premiums and self-funded plan costs will increase 4.6% between 2026 and 2027, to $905 billion. Average employer spending might rise 4.9%, to an average of $9,627 for each of the 180 million plan participants. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Spending Growth Expected to Moderate Slightly: CMS forecasters believe employer health benefit costs will grow more slowly in 2027 than in the prior two years. They estimate spending rose 8.6% in 2025 and 5.8% in 2026, suggesting a gradual deceleration. Even so, overall employer outlays are still projected to climb substantially in dollar terms. By 2034, total employer health benefit spending could reach $1.2 trillion.

2. National Health Costs Continue to Outpace Economic Growth: Overall U.S. health expenditures are projected to reach $6.3 trillion in 2027, reflecting a 4.6% increase. During the same period, gross domestic product is expected to grow 3.6% to $18.3 trillion. As a result, health care is anticipated to account for about 18.8% of GDP, slightly higher than the previous year. This indicates health spending will continue to consume a growing share of the nation’s economic output.

3. Forecast Accuracy Has Recently Improved: Past projections from CMS have produced mixed results when compared with actual spending. For 2023, total health spending came in 2.6% above projections and employer spending was 8.4% higher than expected. However, 2024 estimates were much closer to actual results, with total spending only 0.3% higher and employer spending 0.8% higher than forecast. The narrower gaps may bolster confidence in the agency’s current projections.

AI playing a major role in consumers' healthcare decision-making, survey finds

By Cailey Gleeson – Patients are taking charge of their healthcare with artificial intelligence and other solutions, with 58% of U.S. patients researching symptoms before deciding whether to book an appointment, according to a new report from ZS Impact Institute. Read Full Article...

HVBA Article Summary

1. AI and Search Tools Are Reshaping Patient Behavior: A significant share of patients are turning to digital tools before engaging with the healthcare system. More than a third use traditional search engines for medical information, and a notable portion are using AI tools, with most users reporting that these resources are helpful. This suggests growing consumer confidence in digital health information sources. The trend indicates patients are increasingly comfortable using technology to inform decisions about whether and when to seek care.

2. Consumer Frustration Is Driving Self-Directed Care: The report links rising AI use to dissatisfaction with the healthcare system rather than simple access to new technology. Large portions of respondents delay physician visits, skip routine check-ups for years or stop treatments early. Many also report lacking a primary care physician or experiencing diagnostic delays that worsened their conditions. Together, these behaviors point to systemic gaps that may be pushing patients to seek alternatives outside traditional care pathways.

3. Providers Face Pressure to Adapt Care Models: As patients become more proactive and informed, providers are seeing more requests for specific medications and named therapies. The report recommends that healthcare leaders redesign care pathways and deploy AI tools to improve capacity and continuity. Researchers argue that the traditional model—where patients first turn to the healthcare system for guidance—is shifting. To maintain engagement, providers may need to integrate their own AI-enabled tools to create more connected and responsive care experiences.

How lifestyles are reshaping voluntary benefits

By Laura Mims – For a long time, the voluntary benefits market followed a fairly predictable formula: employers offered traditional options such as life insurance, disability coverage, accident insurance or hospital indemnity plans, and employees chose what made sense for their personal situations. Those benefits are still essential today, but employee expectations of benefits programs are evolving. Read Full Article... ^{_{(Subscription required)}}

HVBA Article Summary

1. Voluntary benefits are expanding beyond traditional insurance: Employers are increasingly looking beyond legacy offerings to address employees’ day-to-day financial realities. In addition to core protections, organizations are considering options such as tuition reimbursement, learning stipends and home office support. Interest in pet insurance is also rising as part of a broader effort to reflect workers’ real-life responsibilities. This shift signals a move toward benefits that align more closely with modern lifestyles rather than standardized packages.

2. Personalization and cost sensitivity are shaping design decisions: Companies recognize that a single benefits package rarely fits a diverse workforce, making voluntary options an attractive way to provide flexibility. Employees tend to feel most comfortable evaluating coverage priced in the $40 to $50 per month range, influencing how products are structured. By offering customizable options at accessible price points, employers can broaden support without significantly raising overall benefits spending. This approach balances meaningful coverage with affordability.

3. Simplicity and broker guidance drive adoption of emerging benefits: Ease of use plays a critical role in whether employees engage with new offerings, particularly when claims processes are involved. For example, some pet insurance claims are processed within about 48 hours, with mobile app submissions designed to reduce friction. Brokers often introduce newer categories such as wellness, mental health and professional development benefits, helping employers understand how they integrate into existing platforms. Close collaboration among carriers, brokers and employers increases the likelihood that innovative benefits will gain traction.

US health spending spikes to $5.7T in 2025, though growth should moderate, CMS finds

By Rebecca Pifer Parduhn – U.S. healthcare spending spiked 7.3% last year to reach $5.7 trillion, driven by soaring spending on hospital services and pricey prescription drugs like GLP-1s, according to new government data. The sharp spending growth isn’t primarily caused by increasing prices. Cost growth has been moderate. Instead, Americans are consuming more healthcare after a lag during the coronavirus pandemic, Centers for Medicare & Medicaid Services actuaries said. It’s the same trend they called out in the national health expenditures report for 2024. Read Full Article...

HVBA Article Summary

1. Utilization, Not Prices, Is Driving Spending Growth: Federal actuaries attribute the recent spike in health expenditures largely to increased use of services rather than rapid price inflation. After pandemic-related delays, Americans are seeking more hospital and clinical care, which has accelerated overall spending. This marks the third straight year that national health spending has risen more than 7%, outpacing overall economic growth. The trend underscores how pent-up demand and higher service use can significantly affect national health expenditures even when price growth remains moderate.

2. Prescription Drugs — Especially GLP-1s — Are a Major Cost Driver: Retail drug spending is projected to grow faster than other major healthcare categories in the coming years. High-cost medications, particularly GLP-1 drugs that can cost around $1,000 per month and are used for diabetes and weight loss, are significantly contributing to the increase. CMS officials said these drugs are pushing up costs in both private insurance and Medicare. Demand for specialty medications for conditions like cancer is also contributing to sustained growth in pharmaceutical spending.

3. Policy Changes Will Reshape Coverage and Payer Mix: CMS projects that the insured share of the population will decline slightly over the next decade, influenced by the expiration of enhanced ACA subsidies and Medicaid funding restrictions. Medicaid spending growth is expected to slow due to funding and enrollment changes, while Medicare spending is forecast to grow at an average annual rate of 7.7% through 2034 as Baby Boomers age into the program. By 2034, Medicare is expected to account for 33% of national healthcare spending, up from 31% in 2024. Overall, health spending is projected to rise from 18% of GDP in 2024 to 20.6% in 2034, reaching $9 trillion.

Millions of Americans could experience hottest July 4th ever

By Kiki Intarasuwan – This July Fourth could be the hottest on record for millions of Americans as a massive heat wave traps more than half of the United States under a heat dome through the holiday weekend. Read Full Article...

HVBA Article Summary

1. Widespread Record-Breaking Heat Expected: Forecasters say heat indices could reach between 100 and 115 degrees from the Midwest to the East Coast as high humidity compounds the danger. More than 300 temperature records, including over 100 daily highs and more than 200 warm overnight lows, could be broken by Saturday. Some locations may surpass records that have stood for more than a century. Temperatures in affected areas are projected to run 20 to 30 degrees above average.

2. Major Cities Implement Emergency Measures: In New York City, officials are deploying medical vans staffed with nurses and paramedics to distribute water and perform wellness checks, while also opening cooling centers across the five boroughs. Nashville has begun heat patrols to provide bottled water to homeless residents during peak heat hours. Washington, D.C., is under an extreme heat watch with forecast highs reaching 103 degrees, potentially surpassing a July 4 record set in 1919. Local leaders are urging residents to limit outdoor exposure and take precautions during holiday events.

3. Serious Health and Fire Risks Accompany the Heat Dome: The heat wave is driven by a heat dome, a system of strong high pressure that traps hot air and prevents relief, especially overnight. Medical experts warn that heat exhaustion symptoms such as fatigue, cramps and dizziness can escalate to heat stroke, which requires immediate emergency care. Heat remains the leading cause of weather-related deaths, and recent European heat waves were linked to more than 1,300 additional deaths. Meanwhile, in the West, dry conditions and high winds have heightened wildfire danger in parts of Utah and southern Colorado, prompting red flag warnings.

What GLP-1s Are Teaching Us About Compulsive Behavior

By Eric Spitznagel – Like so many things on social media, patients invented the term before medicine did. They called it “food noise.” They weren’t talking about ordinary hunger. They were describing something more intrusive and repetitive, a mental broadcast that kept reminding them what was in the pantry, what could be ordered, what could be eaten now and regretted later. Then some patients started taking GLP-1 medications for diabetes or weight loss, and the broadcast faded. Read Full Article...

HVBA Article Summary

1. GLP-1s May Influence Reward Pathways Beyond Appetite: Emerging research suggests GLP-1 receptor agonists affect brain systems involved in motivation and reward, not just blood sugar and satiety. Trials in alcohol use disorder have shown reductions in drinking measures and craving, and a phase 2a study in smokers found decreased nicotine craving even when cigarette consumption did not significantly change. Animal studies indicate these drugs can act on mesolimbic dopamine circuits, potentially reducing the intensity of “wanting” rather than eliminating pleasure. This distinction could help explain why patients describe urges as less intrusive rather than less enjoyable.

2. Observational and Early Clinical Data Suggest Broader Behavioral Effects: A large BMJ cohort study of more than 600,000 US veterans with type 2 diabetes found associations between GLP-1 use and lower risks for incident substance use disorders compared with another diabetes drug class. Among those with preexisting substance use disorders, GLP-1 therapy was linked to fewer substance-related emergency visits, hospitalizations, overdoses, deaths, and suicidal behaviors, though causality cannot be established. Additional research has reported weaker associations between alcohol use, impulsivity, and violent crime among people taking GLP-1s. Anecdotal reports, including reductions in nail-biting, have further fueled interest in their potential impact on compulsive behaviors.

3. Key Question: Targeting Pathologic Compulsion Without Dampening Normal Motivation: Researchers emphasize that reward processing is complex and that GLP-1 drugs may alter cue salience or motivational drive rather than shutting down desire entirely. Scientists are now working to determine whether these medications selectively reduce harmful, excessive cravings or more broadly dampen mesolimbic reward signaling. Some patients have reported emotional flattening or reduced motivation, raising concerns about unintended effects on normal pleasure and goal-directed behavior. Future work will need to identify which patients are most likely to benefit and whether combining GLP-1s with behavioral therapies yields more balanced and personalized outcomes.